AKUMIN INC.
Healthcare · Services-Medical Laboratories · A6 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | $749.6M | $421.1M | $245.6M |
| Operating income | −$28.1M | $13.6M | $25.0M |
| Net income | −$156.8M | −$43.3M | −$36.7M |
| Total assets | $1.77B | $1.92B | $665.1M |
| Total liabilities | $1.62B | $1.60B | $579.9M |
| Equity | −$48.2M | $105.2M | $80.8M |
| EPS (diluted) | $-1.75 | $-0.56 | — |
| Shares out. | 89.0M | 89.0M | 70.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −3.7%
- Net margin
- −20.9%
- Return on equity
- 325.2%
- Return on assets
- −8.9%
- Return on capital (ROCE)
- −1.8%
- Liabilities / assets
- 92.0%
- Debt / equity
- —
- Book value / share
- $-0.54
- Revenue growth (YoY)
- 78.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -0.57distress
- Accruals / assets
- −12.6%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 3 warning● 4 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 14, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Kumar KrishnaOfficer — President and COO | Jul 15, 2023 | Grant | 250,000 | $0.00 |
| Huang HaichenDirector | Apr 7, 2023 | Grant | 102,459 | $0.00 |
| Viviano Paul SDirector | Apr 7, 2023 | Grant | 102,459 | $0.00 |
| Wagner John R.Director | Apr 7, 2023 | Grant | 102,459 | $0.00 |
| Dunford Stanley GDirector | Apr 7, 2023 | Grant | 102,459 | $0.00 |
| Lee MurrayDirector | Apr 7, 2023 | Grant | 102,459 | $0.00 |
| Webb James HaroldDirector | Apr 7, 2023 | Grant | 102,459 | $0.00 |
| Kretschmer R. DavidOfficer — Chief Financial Officer | Apr 7, 2023 | Grant | 150,000 | $0.00 |
| Zine RiadhOfficer — Chief Executive Officer | Apr 7, 2023 | Grant | 700,000 | $0.00 |
| Davies ThomasDirector | Apr 7, 2023 | Grant | 102,459 | $0.00 |
| Navani RohitOfficer — See Remarks | Apr 7, 2023 | Grant | 150,000 | $0.00 |
| Wyper JamesDirector | Mar 31, 2023 | D | 57,078 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Bankruptcy or receivership · New financial obligation · Unregistered equity sale · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosureFeb 7, 2024
- Director / officer change · Regulation FD disclosureJan 2, 2024
- Regulation FD disclosureDec 12, 2023
- Bankruptcy or receivership · New financial obligation · Other material eventDec 5, 2023
- Regulation FD disclosureNov 2, 2023
- Bankruptcy or receivership · Debt acceleration / triggering event · Delisting / listing-standard notice · Other material eventOct 27, 2023
- Bankruptcy or receivership · Debt acceleration / triggering event · Other material eventOct 23, 2023
- Entered a material agreement · Delisting / listing-standard notice · Director / officer change · Regulation FD disclosure · Other material eventOct 20, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.